Stay updated with breaking news from Nasdaq Sera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) shares were up 8% during mid-day trading on Friday . The stock traded as high as $7.74 and last traded at $7.66. Approximately 295,827 shares were traded during trading, an increase of 13% from the average daily volume of 262,132 shares. The stock had previously closed at […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 148,700 shares, an increase of 31.4% from the August 31st total of 113,200 shares. Currently, 1.1% of the company’s shares are short sold. Based on an […]
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]
Riverview Capital Advisers LLC lifted its holdings in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 5.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,731 shares of the company’s stock after buying an additional 5,563 shares during the quarter. […]
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]